Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.2400 (-1.79%) ($116.6300 - $120.8500) on Thu. May. 5, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.22% (three month average) | RSI | 39 | Latest Price | $118.2400(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.11% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.11% (StdDev 2.22%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
Resistance Level | $123.43 | 5 Day Moving Average | $120.48(-1.86%) | 10 Day Moving Average | $123.35(-4.14%) | 20 Day Moving Average | $123.43(-4.2%) | To recent high | -9.3% | To recent low | 37.8% | Market Cap | $1.9b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |